Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options

Journal of Infectious Diseases

Volumn 181, Issue 1, 2000, Pages 176-180

  Gogos, Charalambos A ^a   Drosou, Eugenia ^a   Bassaris, Harry P ^a   Skoutelis, Athanassios ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SEPSIS;

CYTOKINES; FEMALE; GREECE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033969341     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315214     Document Type: Article

References (27)

1. 1. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans, advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 1990; 113:227-40.
2. 2. Pinsky MR, Vincent JL, Deviere J, et al. Serum cytokine levels in human septic shock: relation to multiple-system organ dysfunction and mortality. Chest 1993; 103:565-75.
3. 3. Blackwell TS Christman JW. Sepsis and cytokines: a current status. Br J Anaesth 1996; 77:110-7.
4. 4. Marchant A, Deviere J, Byl B, De Groote D, Vincent J, Goldman M. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 1995; 172:296-301.
5. 5. Friedman G, Jankowski S, Marchant A, Goldman M, Kahn RJ, Vincent JL. Blood interleukin-10 levels parallel the severity of septic shock. J Crit Care 1997; 12:183-7.
6. 6. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89:4845-9.
7. 7. Pruitt JH, Edwards PD, Harward RRS, et al. Soluble interleukin-1 type-II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 1996; 87:3282-8.
8. 8. Waage A, Halstensen A, Espevick T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1:355-7.
9. 9. Girardin E, Grau CE, Dayer JM, Roux-Lombard P, J5 study group. Lambert PH. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988; 319:397-400.
10. 10. Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis: human IL-6 as a marker of severity. Ann Surg 1992; 215:356-62.
11. 11. Lehmann AK, Halstensen A, Sornes S, Rokke O, Waage A. High levels of interleukin-10 in serum are associated with fatality in meningococcal disease. Infect Immun 1995; 63:2109-12.
12. 12. Hazelcet JA, Kornelisse RF, van der Pouw Kraan TC, et al. Interleukin-12 levels during the initial phase of septic shock with purpura in children: relation to severity of disease. Cytokine 1997; 9:711-6.
13. 13. Kasai T, Inada K, Takakuwa T, Yamada H, et al. Anti-inflammatory cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 1997; 98:34-42.
14. 14. Van der Poll T, de Waal Malefyt R, Coyle SM, Lowry SF. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10 and IL-13. J Infect Dis 1997; 175:118-22.
15. 15. Wray GM, Hinds CJ. Determinants of outcome from sepsis and septic shock. In: Vincent JL ed. Yearbook of intensive care and emergency medicine. Berlin: Springer-Verlag, 1997:168-79.
16. 16. Sibbald WJ, Vincent JL. Round table conference on clinical trials for the treatment of sepsis. Crit Care Med 1995; 23:394-9.
17. 17. American College of Chest Physicians/Society of Critical Medicine Consensus Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
18. 18. Auriant I, Vinatier I, Thaler F, Tourneur M, Loirat P. Simplified acute physiology score II for measuring severity of illness in intermediate care units. Crit Care Med 1998; 26:1368-71.
19. 19. Van Zee KJ, DeForge LE, Fischer E, et al. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 1991; 146:3478-82.
20. 20. Bone RC, Grodzin CJ, Balk RA. Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997; 112:235-43.
21. 21. Cavaillon JM. Pathophysiological role of pro-and anti-inflammatory cytokines in sepsis. In: Reinhart K ed. The diagnosis of sepsis: current prospectives. Boston: Kluwer Academic Publishers, 1998:127-40.
22. 22. Dofferhoff ASM, Buys J. Effects of antibiotics on cytokine release. In: Vincent JL ed. Yearbook of intensive care and emergency medicine. Berlin: Springer-Verlag. 1995:465-72.
23. 23. Van Dissel JT, van Langevelde P, Westendorp RGL, Kwappenberg K, Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998; 351:950-3.
24. 24. Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 1991; 91:23-9.
25. 25. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994; 83: 113-8.
26. 26. Alexander HR, Sheppard BC, Jensen JC, et al. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension and hypothermia of gram-negative sepsis. J Clin Invest 1991; 88:34-9.
27. 27. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997; 25:1095-100.